DFH Pharma, Inc
Gaithersburg, MD · Biotech · Private
Next-generation maturation inhibitors (MIs) that block HIV capsid maturation and retain activity against drug-resistant viral strains
- Grants
- $3.2M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $171,475 | |
| Federal grant | Department of Health and Human Services · Phase I · Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $171,475 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $518,708 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $943,084 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $424,376 | |
| Federal grant | Department of Health and Human Services · Phase II · IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents | $986,894 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2735 | INCOMPUTABLE LLC | — | — |
| 2736 | HYDROGENE THERAPEUTICS INC | — | — |
| 2737 | LUNA BIOSCIENCE, INC. | — | — |
| 2738 | DFH Pharma, Inc | — | — |
| 2739 | MIXEDLCMEDIA LLC | — | — |
| 2740 | LUCEOME BIOTECHNOLOGIES, LLC | — | — |
| 2741 | PROTEIN ENGINES LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.